SCHOTT Pharma

SCHOTT Pharma is a provider of drug containment and delivery solutions for injectables, ranging from prefillable syringes, to cartridges, vials, and ampoules. It manufactures syriQ BioPure® glass prefillable syringes for biologics, and SCHOTT TOPPAC prefillable syringes, made of COP.


Visit Website

Headquarters
SCHOTT Pharma AG & Co KGaA
Hattenbergstrasse 10
55122 Mainz
Germany

Phone / Contact

T: +49 6131 66-0
E: [email protected]

Connect

SCHOTT Pharma designs drug containment and delivery solutions grounded in science to ensure that medications are safe and easy to use. The company’s portfolio ranges from prefillable glass and polymer syringes to cartridges, vials and ampoules. SCHOTT employs a team of around 4,700 people from over 60 countries and is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America and Asia. SCHOTT holds over 1,000 patents and technologies and develops innovative technologies in a state-of-the-art R&D centre in Switzerland.

SCHOTT Pharma AG & Co KGaA is headquartered in Mainz, Germany and listed on the Frankfurt Stock Exchange as part of the MDAX. The company is part of SCHOTT AG, which is owned by the Carl Zeiss Foundation. SCHOTT Pharma is committed to sustainable development with the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1,800 customers, including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of €957 million (£793 million) in the 2024 fiscal year.

Articles by SCHOTT Pharma

Top